United States Breast Cancer Market Expected to Witness a Sustainable Growth over 2022

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.

Long–term Growth Projection:

  • Mammography grasp the dominant share in the United States Breast Cancer Screening Market
  • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
  • Number of mammograpy screening population in the United States will increase to more than 50 Million by 2022

Market growth can be attributed to factors such as increased incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 – 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in-depth analysis of breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in the United States. Furthermore, the report also covered the mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes an assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.

The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products, and latest development and trends

Key Topics Covered in the Report

  • United States Breast Cancer Cases (2010 – 2022)
  • United States Breast Cancer Mammography Screening Population (2010 – 2022)
  • United States Breast Cancer Death (2010 – 2017)
  • Market Overview: United States Breast Cancer Screening (2010 – 2022)
  • Market Share: United States Breast Cancer Screening (2010 – 2022)
  • By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
  • Reimbursement Policies of the United States Breast Cancer Screening
  • Breast Cancer Screening Market Clinical Trial Insight by Phase, Company & Country
  • Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
  • Key Manufacturers Analysis

Major Breast Cancer Screening Analyzed Under This Report Are:

  • Mammography
  • Breast Magnetic Resonance Imaging(MRI)
  • Breast Ultrasound

Major Companies Covered in This Report:

  • Hitachi Medical Corporation
  • Siemen Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • GE Healthcare
  • Hologic

Key Topics Covered:

1. Executive Summary

2. Breast Cancer Facts

3. United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010–2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death

4. Market Overview: United States Breast Cancer Screening (2010 – 2022)

5. Market Share: United States Breast Cancer Screening (2010 – 2022)

6. By Types: Market Size & Analysis (2010 – 2022)
6.1 Mammography Screening Market
6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
6.3 Breast Ultrasound Screening Market

7. Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
7.1 Market Drivers
7.2 Market Inhibitors

8. Reimbursement Policies of the United States Breast Cancer Screening
8.1 Mammography
8.2 Breast Magnetic Resonance Imaging(MRI)
8.3 Breast Ultrasound

9. Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2017
9.2 Year 2016
9.3 Year 2015

10. Key Manufacturers Analysis
10.1 Hologic
10.1.1 Business Overview
10.1.2 Breast Cancer Screening – Marketed Products
10.1.2.1 Mammography
10.1.2.2 Magnetic Resonance Imaging(MRI)
10.1.3 Breast Cancer Screening – Latest Development & Trends
10.2 Hitachi Medical Corporation
10.2.1 Business Overview
10.2.2 Breast Cancer Screening – Marketed Products
10.2.2.1 Magnetic Resonance Imaging(MRI)
10.2.2.2 Ultrasound
10.2.3 Breast Cancer Screening – Latest Development & Trends
10.3 Siemens Healthineers
10.3.1 Business Overview
10.3.2 Breast Cancer Screening – Marketed Products
10.3.2.1 Mammography
10.3.2.2 Magnetic Resonance Imaging (MRI)
10.3.3 Breast Cancer Screening – Latest Development & Trends
10.4 Philips Healthcare
10.4.1 Business Overview
10.4.2 Breast Cancer Screening – Marketed Products
10.4.2.1 Mammography
10.4.2.2 Magnetic Resonance Imaging (MRI)
10.4.2.3 Ultrasound
10.4.3 Breast Cancer Screening – Latest Development & Trends
10.5 Toshiba Medical Systems Corporation
10.5.1 Business Overview
10.5.2 Breast Cancer Screening – Marketed Products
10.5.2.1 Mammography
10.5.2.2 Magnetic Resonance Imaging (MRI)
10.5.2.3 Ultrasound
10.5.3 Breast Cancer Screening – Latest Development & Trends
10.6 GE Healthcare
10.6.1 Business Overview
10.6.2 Breast Cancer Screening – Marketed Products
10.6.2.1 Mammography
10.6.2.2 Magnetic Resonance Imaging (MRI)
10.6.2.3 Ultrasound
10.6.3 Breast Cancer Screening – Latest Development & Trends

Buy this premium research report @ https://dpiresearch.com/reports/united-states-breast-cancer-screening-market-analysis-by-type-share-cases-clinical-trials-insight-reimbursement-competitive-strategies-and-forecast-2017-2022/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact US:

Maria Rai
Sales Manager 
Call: +91 766 764 8693
Email: 
sales@dpiresearch.com
Full Address: Mehrauli, New Delhi, India,110030
Website: 
dpiresearch.com

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *